Patients with ulcerative colitis have impaired expression of pparγ in the colon and the increased expression of this gene can lead to the inhibition of inflammatory cytokines such as IL-1β and TNF-α (Dubuquoy et al., 2006). The gene discussed is PPARG; the disease is ulcerative colitis.